2020
DOI: 10.1021/acsmedchemlett.0c00387
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of Potent and Selective 7-Azaindole Isoindolinone-Based PI3Kγ Inhibitors

Abstract: The successful application of immunotherapy in the treatment of cancer relies on effective engagement of immune cells in the tumor microenvironment. Phosphoinositide 3-kinase γ (PI3Kγ) is highly expressed in tumor-associated macrophages, and its expression levels are associated with tumor immunosuppression and growth. Selective inhibition of PI3Kγ offers a promising strategy in immuno-oncology, which has led to the development of numerous potent PI3Kγ inhibitors with variable selectivity profiles. To facilitat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 29 publications
0
13
0
Order By: Relevance
“…On the other hand, from a safety perspective, a high isoform selectivity is required, especially toward PI3Kα and β, which made development of PI3Kγ inhibitors difficult, due to the high similarity between isoform sequences. Only recently, new classes of increasingly more specific inhibitors have been generated to block PI3Kγ kinase activity [ 108 – 110 ]. However, this approach may not discriminate between the two PI3Kγ heteromeric variants, that share the same catalytic p110γ subunit combined to different regulatory subunits, which hypothetically exert distinct biological functions [ 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, from a safety perspective, a high isoform selectivity is required, especially toward PI3Kα and β, which made development of PI3Kγ inhibitors difficult, due to the high similarity between isoform sequences. Only recently, new classes of increasingly more specific inhibitors have been generated to block PI3Kγ kinase activity [ 108 – 110 ]. However, this approach may not discriminate between the two PI3Kγ heteromeric variants, that share the same catalytic p110γ subunit combined to different regulatory subunits, which hypothetically exert distinct biological functions [ 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…A few phosphoinositide-3-kinase γ(PI3Kγ) inhibitors share common H-bonding donor and acceptor motifs ( Figure 32 ). 122 The bicyclic ring in inhibitors engages in a bidentate manner with Val882, a hinge motif of PI3Kγ. Hence, this bidentate interaction is a determining factor of the potency of different substituted isoindolenones ( Figure 32 ).…”
Section: Dengue and Ebola Virusesmentioning
confidence: 99%
“…Isoindolinones represent an important class of biologically active small molecules, [4] and have seen increasing use in medicinal chemistry. [5] Of particular interest to our group are tricyclic isoindolinones, which have shown to have antiinflammatory, [6] anti-addictive [7] and CNS modulating effects (Figure 1). [8] Their synthesis often relies upon a linear strategy to build the tricyclic core, which somewhat impedes its use in modular synthesis, with low yielding condensation reactions routinely employed.…”
Section: Introductionmentioning
confidence: 99%
“…Isoindolinones represent an important class of biologically active small molecules, [4] and have seen increasing use in medicinal chemistry [5] . Of particular interest to our group are tricyclic isoindolinones, which have shown to have anti‐inflammatory, [6] anti‐addictive [7] and CNS modulating effects (Figure 1).…”
Section: Introductionmentioning
confidence: 99%